Forbes

PCOS has been renamed PMOS. Here's what the change means for the millions of women living with this misunderstood, often misdiagnosed condition

Kordata, a BIOS Ltd spinout, will advance next-generation clinical trial sites powered with neural recording technologies and enterprise b2b capabilities.

Drug overdose deaths fell sharply in 2024, marking a historic decline. But public health experts warn the deeper addiction crisis may be far from over.

A new Indeed report suggests there will still be job growth, but not in all fields. Here’s how employers and workers must adapt to avoid 8% unemployment.

The Surgeon General published a new advisory on screen use. A public health expert discusses what the science says about risks and benefits of screens.

In this week’s edition of InnovationRx, we look at a new AI drug development deal, a pill for sleep apnea, Commure’s $7 billion valuation, nd more.

E-cigarettes containing nicotine can help people quit smoking according to a new study and may be more helpful for some smokers than other nicotine products like patches.

The ARISE network is studying what AI can actually do in clinical care, how it should be evaluated, and what it reveals about clinical reasoning itself.

An emergency physician explains how U.S. hospitals screen and respond to Ebola cases as the first American tests positive amid the 2026 DRC outbreak.

Physician assistants continue to increase in number and so is their pay, hitting $140,000 as their ranks have grown to more than 200,000.

A 41-year-old died of gastric cancer in 11 weeks. His widow shares what no one tells you about life after losing a spouse to cancer.

In a worldwide first, a one-and-done gene therapy has been approved to treat a form of hereditary deafness. Many of the children treated can hear normally and speak.

Deductibles for Americans enrolled in Obamacare rose by more than $1,000 on average this year after the Republican-led Congress didn’t renew enhanced tax credits.

As peptides grow more mainstream, experts weigh in on sourcing, safety, transparency, telemedicine, and what consumers should know before starting peptide therapies.